drugset / Trial / NCT00798395

A Study to Assess the Effect of Single and Multiple Doses Org 50081 and a Single Dose of Zopiclone on Next-day Driving Ability and Psychomotor Performance in Healthy Volunteers. (P05794) (COMPLETED)

NCT00798395

Phase 1 Completed 32 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverDouble-blindTreatment

Summary

This trial is to investigate the effect on next-day driving performance and psychomotor performance in healthy volunteers.

Timeline

Start
2007-10
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmirtazapine Small molecule 1.5 mg
Subject Esmirtazapine Small molecule 4.5 mg
Comparator Zopiclone Small molecule 7.5 mg